Healthcare - Biotechnology - NASDAQ - GB
$ 0.5866
-0.778 %
$ 150 M
Market Cap
-1.63
P/E
CASH FLOW STATEMENT
-141 M
OPERATING CASH FLOW
177 M
INVESTING CASH FLOW
880 K
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Adaptimmune Therapeutics plc
| Net Income | -114 M |
| Depreciation & Amortization | 9.45 M |
| Capital Expenditures | -4.88 M |
| Stock-Based Compensation | 11.8 M |
| Change in Working Capital | -25 M |
| Others | -48.2 M |
| Free Cash Flow | -146 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Jun-2015 | Jun-2014 | Jun-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||
| Net Income | (113.9) | (165.5) | (158.1) | (130.1) | (137.2) | (95.5) | (70.1) | (71.6) | (23.7) | (14.4) | (9.3) |
| Depreciation & Amortization | 9.5 | 6.1 | 6.6 | 7.6 | 8.0 | 7.8 | 5.4 | 3.3 | 0.7 | 0.3 | 45.6 K |
| Deferred Income Tax | 0 | 0 | 5.8 | 2.5 | 1.1 | 12.2 | (8.0) | 0 | 0 | 1.2 | 0 |
| Stock Based Compensation | 11.8 | 18.2 | 20.6 | 10.4 | 11.1 | 0 | 10.8 | 8.8 | 4.2 | 0.3 | 0.2 |
| Other Operating Activities | (23.2) | 0.9 | 1.2 | 55 K | (0.2) | 0.2 | 0.3 | (1.2) | (0.3) | 1.7 K | 0.5 |
| Change in Working Capital | (25.0) | (1.5) | 134.6 | 56.0 | 4.7 | (45.3) | 7.2 | 12.5 | (13.7) | 49.8 | 0.9 |
| Cash From Operations | (140.9) | (141.8) | 10.7 | (53.6) | (112.5) | (104.4) | (54.3) | (48.2) | (32.7) | 37.2 | (7.8) |
| INVESTING CASH FLOW | |||||||||||
| Capital Expenditures | (4.9) | (29.7) | (8.8) | (2.9) | (3.1) | (4.7) | (25.0) | (12.8) | (5.1) | (1.4) | (0.2) |
| Other Items | 181.4 | 118.9 | 84.6 | (276.0) | 98.0 | (12.7) | (101.1) | 30.5 | (55.2) | 0 | 0 |
| Cash From Investing Activities | 176.5 | 89.1 | 75.8 | (278.9) | 94.9 | (17.5) | (126.1) | 17.8 | (60.3) | (1.4) | (0.2) |
| FINANCING CASH FLOW | |||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (1.3) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.3 | 50 K | 0.8 | 5.7 | 0.4 | 102.7 | 0.4 | 17 K | 176.0 | (159.1) | (10.8) |
| Cash From Financing Activities | 0.9 | 12.9 | 3.3 | 340.1 | 0.4 | 102.7 | 103.6 | 17 K | 0 | 16.9 | 3.7 |
| CHANGE IN CASH | |||||||||||
| Net Change In Cash | 37.4 | (42.1) | 90.2 | 6.6 | (17.6) | (15.8) | (74.5) | (36.0) | 181.7 | 52.7 | (4.2) |
| FREE CASH FLOW | |||||||||||
| Free Cash Flow | (145.8) | (171.5) | 1.9 | (56.5) | (115.6) | (109.1) | (79.3) | (61.0) | (37.8) | 35.8 | (7.9) |